这是一篇来自已证抗体库的有关人类 CXCR3的综述,是根据51篇发表使用所有方法的文章归纳的。这综述旨在帮助来邦网的访客找到最适合CXCR3 抗体。
CXCR3 同义词: CD182; CD183; CKR-L2; CMKAR3; GPR9; IP10-R; Mig-R; MigR; C-X-C chemokine receptor type 3; G protein-coupled receptor 9; IP-10 receptor; Mig receptor; chemokine (C-X-C motif) receptor 3; chemokine receptor 3; interferon-inducible protein 10 receptor

BioLegend
小鼠 单克隆(G025H7)
  • 流式细胞仪; 人类; 图 3c
BioLegend CXCR3抗体(Biolegend, G025H7)被用于被用于流式细胞仪在人类样本上 (图 3c). Front Immunol (2019) ncbi
小鼠 单克隆(G025H7)
  • 流式细胞仪; 人类; 图 5b
BioLegend CXCR3抗体(BioLegend, 353713)被用于被用于流式细胞仪在人类样本上 (图 5b). Nat Immunol (2018) ncbi
小鼠 单克隆(G025H7)
  • 流式细胞仪; 人类; 图 5a
BioLegend CXCR3抗体(BioLegend, GO25H7)被用于被用于流式细胞仪在人类样本上 (图 5a). PLoS ONE (2017) ncbi
小鼠 单克隆(G025H7)
  • mass cytometry; 人类; 图 2a
BioLegend CXCR3抗体(Biolegend, G025H7)被用于被用于mass cytometry在人类样本上 (图 2a). Proc Natl Acad Sci U S A (2017) ncbi
小鼠 单克隆(G025H7)
  • 流式细胞仪; 人类; 图 2b
BioLegend CXCR3抗体(BioLegend, G025H7)被用于被用于流式细胞仪在人类样本上 (图 2b). Sci Rep (2017) ncbi
小鼠 单克隆(G025H7)
  • 流式细胞仪; 人类; 图 7b
BioLegend CXCR3抗体(BioLegend, G025H7)被用于被用于流式细胞仪在人类样本上 (图 7b). elife (2017) ncbi
小鼠 单克隆(G025H7)
  • 流式细胞仪; 人类; 图 2a
BioLegend CXCR3抗体(BioLegend, G025H7)被用于被用于流式细胞仪在人类样本上 (图 2a). Science (2017) ncbi
小鼠 单克隆(G025H7)
  • 流式细胞仪; 人类; 图 s3c
BioLegend CXCR3抗体(BioLegend, G025H7)被用于被用于流式细胞仪在人类样本上 (图 s3c). J Clin Invest (2017) ncbi
小鼠 单克隆(G025H7)
  • 流式细胞仪; 人类; 图 s1a
BioLegend CXCR3抗体(BioLegend, G025H7)被用于被用于流式细胞仪在人类样本上 (图 s1a). JCI Insight (2017) ncbi
小鼠 单克隆(G025H7)
  • 流式细胞仪; 人类; 图 2b
BioLegend CXCR3抗体(Biolegend, G02SH7)被用于被用于流式细胞仪在人类样本上 (图 2b). Genome Med (2017) ncbi
小鼠 单克隆(G025H7)
  • 流式细胞仪; 人类; 图 5b
BioLegend CXCR3抗体(Biolegend, 353716)被用于被用于流式细胞仪在人类样本上 (图 5b). Sci Rep (2017) ncbi
小鼠 单克隆(G025H7)
  • 流式细胞仪; 人类; 图 2a
BioLegend CXCR3抗体(Biolegend, G025H7)被用于被用于流式细胞仪在人类样本上 (图 2a). Proc Natl Acad Sci U S A (2016) ncbi
小鼠 单克隆(G025H7)
  • 流式细胞仪; 人类; 图 3a
BioLegend CXCR3抗体(Biolegend, G025H7)被用于被用于流式细胞仪在人类样本上 (图 3a). PLoS ONE (2016) ncbi
小鼠 单克隆(G025H7)
  • 流式细胞仪; 人类; 图 s2d
BioLegend CXCR3抗体(BioLegend, G025H7)被用于被用于流式细胞仪在人类样本上 (图 s2d). J Immunol (2016) ncbi
小鼠 单克隆(G025H7)
  • 流式细胞仪; 人类; 表 1
BioLegend CXCR3抗体(BioLegend, G025H7)被用于被用于流式细胞仪在人类样本上 (表 1). J Immunol (2016) ncbi
小鼠 单克隆(G025H7)
  • 流式细胞仪; 人类; 图 1
BioLegend CXCR3抗体(Biolegend, G025H7)被用于被用于流式细胞仪在人类样本上 (图 1). Oncoimmunology (2016) ncbi
小鼠 单克隆(G025H7)
  • 流式细胞仪; 人类; 图 1a
BioLegend CXCR3抗体(biolegend, G025H7)被用于被用于流式细胞仪在人类样本上 (图 1a). J Immunol (2016) ncbi
小鼠 单克隆(G025H7)
  • 流式细胞仪; 人类; 图 7a
BioLegend CXCR3抗体(BioLegend, G025H7)被用于被用于流式细胞仪在人类样本上 (图 7a). J Allergy Clin Immunol (2016) ncbi
小鼠 单克隆(G025H7)
  • 流式细胞仪; 人类; 图 3
BioLegend CXCR3抗体(Biolegend, G025H7)被用于被用于流式细胞仪在人类样本上 (图 3). Mucosal Immunol (2016) ncbi
小鼠 单克隆(G025H7)
  • 流式细胞仪; 人类; 图 3
BioLegend CXCR3抗体(Biolegend, G025H7)被用于被用于流式细胞仪在人类样本上 (图 3). Clin Cancer Res (2015) ncbi
小鼠 单克隆(G025H7)
BioLegend CXCR3抗体(BioLegend, G025H7)被用于. Clin Cancer Res (2014) ncbi
安迪生物R&D
小鼠 单克隆(49801)
  • 流式细胞仪; 人类; 图 3a
安迪生物R&D CXCR3抗体(R&D, 49801)被用于被用于流式细胞仪在人类样本上 (图 3a). J Virol (2017) ncbi
小鼠 单克隆(49801)
  • 流式细胞仪; 人类; 图 4
安迪生物R&D CXCR3抗体(R&D Systems, 49801)被用于被用于流式细胞仪在人类样本上 (图 4). J Allergy Clin Immunol (2018) ncbi
赛默飞世尔
小鼠 单克隆(CEW33D)
  • 流式细胞仪; 人类; 1:200; 图 2c
赛默飞世尔 CXCR3抗体(eBioscience, 12-1839-42)被用于被用于流式细胞仪在人类样本上浓度为1:200 (图 2c). elife (2019) ncbi
兔 多克隆
  • 免疫组化-石蜡切片; 人类; 1:100
赛默飞世尔 CXCR3抗体(Thermo Fisher Scientific, PA1-32503)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:100. Mol Med Rep (2014) ncbi
艾博抗(上海)贸易有限公司
小鼠 单克隆(49801)
  • 免疫组化-石蜡切片; 人类; 0.5 ug/ml
艾博抗(上海)贸易有限公司 CXCR3抗体(Abcam, ab64714)被用于被用于免疫组化-石蜡切片在人类样本上浓度为0.5 ug/ml. Br J Cancer (2014) ncbi
兔 多克隆
  • 免疫组化; 人类; 1:150
  • 免疫印迹; 人类; 1:1000
艾博抗(上海)贸易有限公司 CXCR3抗体(Abcam, ab71864)被用于被用于免疫组化在人类样本上浓度为1:150 和 被用于免疫印迹在人类样本上浓度为1:1000. J Clin Immunol (2013) ncbi
LifeSpan Biosciences
小鼠 单克隆(2AR1)
  • 抑制或激活实验; 人类
  • 中和反应; 人类
LifeSpan Biosciences CXCR3抗体(LifeSpan, LS-C6283-500)被用于被用于抑制或激活实验在人类样本上 和 被用于中和反应在人类样本上. Nat Commun (2015) ncbi
小鼠 单克隆(2AR1)
  • 免疫组化-石蜡切片; 人类; 1:20000
LifeSpan Biosciences CXCR3抗体(LifeSpan Biosciences, LS-C6283)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:20000. J Clin Oncol (2010) ncbi
武汉三鹰
小鼠 单克隆(1B2D6)
  • 免疫印迹; 人类; 1:1000; 图 5b
武汉三鹰 CXCR3抗体(Proteintech, 60065-1-1g)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 5b). Hum Pathol (2015) ncbi
碧迪BD
小鼠 单克隆(1C6/CXCR3)
  • 流式细胞仪; 人类; 图 3d
碧迪BD CXCR3抗体(BD, 560832)被用于被用于流式细胞仪在人类样本上 (图 3d). J Clin Invest (2018) ncbi
小鼠 单克隆(6C6)
  • 流式细胞仪; 人类; 图 1a
碧迪BD CXCR3抗体(BD Pharmigen, 6C6)被用于被用于流式细胞仪在人类样本上 (图 1a). Arthritis Res Ther (2018) ncbi
小鼠 单克隆(6C6)
  • 流式细胞仪; 人类; 图 1a
碧迪BD CXCR3抗体(BD Biosciences, 551127)被用于被用于流式细胞仪在人类样本上 (图 1a). elife (2018) ncbi
小鼠 单克隆(1C6/CXCR3)
  • 流式细胞仪; 人类; 图 1
碧迪BD CXCR3抗体(BD Biosciences, 557185)被用于被用于流式细胞仪在人类样本上 (图 1). J Cell Physiol (2017) ncbi
小鼠 单克隆(6C6)
  • 流式细胞仪; 人类; 图 1
碧迪BD CXCR3抗体(BD Biosciences, 555933)被用于被用于流式细胞仪在人类样本上 (图 1). J Cell Physiol (2017) ncbi
小鼠 单克隆(1C6/CXCR3)
  • 流式细胞仪; 人类; 图 1b
碧迪BD CXCR3抗体(BD Pharmingen, 560831)被用于被用于流式细胞仪在人类样本上 (图 1b). Sci Rep (2017) ncbi
小鼠 单克隆(6D4/D6/G2)
  • 流式细胞仪; 人类; 图 5c
碧迪BD CXCR3抗体(BD, 555048)被用于被用于流式细胞仪在人类样本上 (图 5c). J Extracell Vesicles (2017) ncbi
小鼠 单克隆(6C6)
  • 流式细胞仪; 人类
碧迪BD CXCR3抗体(BD Bioscience, 6C6)被用于被用于流式细胞仪在人类样本上. Int J Cancer (2017) ncbi
小鼠 单克隆(6C6)
  • 流式细胞仪; 人类; 1:5; 图 5
  • 免疫细胞化学; 人类; 图 6
碧迪BD CXCR3抗体(BD Bioscience, 555933)被用于被用于流式细胞仪在人类样本上浓度为1:5 (图 5) 和 被用于免疫细胞化学在人类样本上 (图 6). Oncotarget (2016) ncbi
小鼠 单克隆(1C6/CXCR3)
  • 流式细胞仪; 人类; 图 1c
碧迪BD CXCR3抗体(BD, 1C6/CXCR3)被用于被用于流式细胞仪在人类样本上 (图 1c). AIDS Res Hum Retroviruses (2016) ncbi
小鼠 单克隆(1C6/CXCR3)
  • 流式细胞仪; 人类; 图 2a
碧迪BD CXCR3抗体(BD, 1C6/CXCR3)被用于被用于流式细胞仪在人类样本上 (图 2a). PLoS ONE (2016) ncbi
小鼠 单克隆(1C6/CXCR3)
  • 流式细胞仪; 猕猴; 1:50
碧迪BD CXCR3抗体(BD Biosciences, 562451)被用于被用于流式细胞仪在猕猴样本上浓度为1:50. Nat Med (2016) ncbi
小鼠 单克隆(1C6/CXCR3)
  • 流式细胞仪; 人类; 图 5d
碧迪BD CXCR3抗体(BD Biosciences, 1C6/CXCR3)被用于被用于流式细胞仪在人类样本上 (图 5d). J Immunol (2016) ncbi
小鼠 单克隆(1C6/CXCR3)
  • 流式细胞仪; 人类; 图 st1
碧迪BD CXCR3抗体(BD, 557185)被用于被用于流式细胞仪在人类样本上 (图 st1). Exp Cell Res (2016) ncbi
小鼠 单克隆(6C6)
  • 流式细胞仪; 人类; 图 st1
碧迪BD CXCR3抗体(BD, 555933)被用于被用于流式细胞仪在人类样本上 (图 st1). Exp Cell Res (2016) ncbi
小鼠 单克隆(1C6/CXCR3)
  • 免疫组化-石蜡切片; 人类; 图 6a
碧迪BD CXCR3抗体(BD Biosciences, 557183)被用于被用于免疫组化-石蜡切片在人类样本上 (图 6a). Clin Exp Immunol (2016) ncbi
小鼠 单克隆(6C6)
  • 流式细胞仪; 人类
碧迪BD CXCR3抗体(BD Pharmingen, 551126)被用于被用于流式细胞仪在人类样本上. Cytometry A (2015) ncbi
小鼠 单克隆(1C6/CXCR3)
  • 流式细胞仪; 人类; 图 2b,2e
碧迪BD CXCR3抗体(BD, 561320)被用于被用于流式细胞仪在人类样本上 (图 2b,2e). PLoS Pathog (2015) ncbi
小鼠 单克隆(1C6/CXCR3)
  • 流式细胞仪; 人类
碧迪BD CXCR3抗体(BD Biosciences, 1C6/CXCR3)被用于被用于流式细胞仪在人类样本上. Clin Immunol (2015) ncbi
小鼠 单克隆(1C6/CXCR3)
  • 流式细胞仪; 人类; 表 2
碧迪BD CXCR3抗体(BD Bioscience, 1C6/CXR3)被用于被用于流式细胞仪在人类样本上 (表 2). Cytometry B Clin Cytom (2014) ncbi
小鼠 单克隆(1C6/CXCR3)
  • 流式细胞仪; 人类
碧迪BD CXCR3抗体(BD Biosciences, 1C6/CXCR3)被用于被用于流式细胞仪在人类样本上. Cytotherapy (2015) ncbi
小鼠 单克隆(1C6/CXCR3)
  • 流式细胞仪; 人类
碧迪BD CXCR3抗体(BD, 1c6/CXCR3)被用于被用于流式细胞仪在人类样本上. Front Immunol (2014) ncbi
小鼠 单克隆(1C6/CXCR3)
  • 流式细胞仪; 人类; 图 3
碧迪BD CXCR3抗体(BD, 1C6/CXCR3)被用于被用于流式细胞仪在人类样本上 (图 3). Ann Rheum Dis (2014) ncbi
文章列表
  1. Zumaquero E, Stone S, Scharer C, Jenks S, Nellore A, Mousseau B, et al. IFNγ induces epigenetic programming of human T-bethi B cells and promotes TLR7/8 and IL-21 induced differentiation. elife. 2019;8: pubmed 出版商
  2. Thauland T, Pellerin L, Ohgami R, Bacchetta R, Butte M. Case Study: Mechanism for Increased Follicular Helper T Cell Development in Activated PI3K Delta Syndrome. Front Immunol. 2019;10:753 pubmed 出版商
  3. Kong X, Martinez Barricarte R, Kennedy J, Mele F, Lazarov T, Deenick E, et al. Disruption of an antimycobacterial circuit between dendritic and helper T cells in human SPPL2a deficiency. Nat Immunol. 2018;19:973-985 pubmed 出版商
  4. Burton A, Pallett L, McCoy L, Suveizdyte K, Amin O, Swadling L, et al. Circulating and intrahepatic antiviral B cells are defective in hepatitis B. J Clin Invest. 2018;128:4588-4603 pubmed 出版商
  5. Armas González E, Domínguez Luis M, Díaz Martín A, Arce Franco M, Castro Hernandez J, Danelon G, et al. Role of CXCL13 and CCL20 in the recruitment of B cells to inflammatory foci in chronic arthritis. Arthritis Res Ther. 2018;20:114 pubmed 出版商
  6. Lee C, Zhang H, Singh S, Koo L, Kabat J, Tsang H, et al. C/EBPδ drives interactions between human MAIT cells and endothelial cells that are important for extravasation. elife. 2018;7: pubmed 出版商
  7. Jeffery H, McDowell P, Lutz P, Wawman R, Roberts S, Bagnall C, et al. Human intrahepatic ILC2 are IL-13positive amphiregulinpositive and their frequency correlates with model of end stage liver disease score. PLoS ONE. 2017;12:e0188649 pubmed 出版商
  8. Hensel M, Peng T, Cheng A, De Rosa S, Wald A, Laing K, et al. Selective Expression of CCR10 and CXCR3 by Circulating Human Herpes Simplex Virus-Specific CD8 T Cells. J Virol. 2017;91: pubmed 出版商
  9. Chew V, Lai L, Pan L, Lim C, Li J, Ong R, et al. Delineation of an immunosuppressive gradient in hepatocellular carcinoma using high-dimensional proteomic and transcriptomic analyses. Proc Natl Acad Sci U S A. 2017;114:E5900-E5909 pubmed 出版商
  10. Allan D, Cerdeira A, Ranjan A, Kirkham C, Aguilar O, Tanaka M, et al. Transcriptome analysis reveals similarities between human blood CD3- CD56bright cells and mouse CD127+ innate lymphoid cells. Sci Rep. 2017;7:3501 pubmed 出版商
  11. Lepore M, Kalinichenko A, Calogero S, Kumar P, Paleja B, Schmaler M, et al. Functionally diverse human T cells recognize non-microbial antigens presented by MR1. elife. 2017;6: pubmed 出版商
  12. See P, Dutertre C, Chen J, Günther P, McGovern N, Irac S, et al. Mapping the human DC lineage through the integration of high-dimensional techniques. Science. 2017;356: pubmed 出版商
  13. Cottineau J, Kottemann M, Lach F, Kang Y, Vély F, Deenick E, et al. Inherited GINS1 deficiency underlies growth retardation along with neutropenia and NK cell deficiency. J Clin Invest. 2017;127:1991-2006 pubmed 出版商
  14. Buskermolen J, Roffel S, Gibbs S. Stimulation of oral fibroblast chemokine receptors identifies CCR3 and CCR4 as potential wound healing targets. J Cell Physiol. 2017;232:2996-3005 pubmed 出版商
  15. Singh A, Subhi Y, Krogh Nielsen M, Falk M, Matzen S, Sellebjerg F, et al. Systemic frequencies of T helper 1 and T helper 17 cells in patients with age-related macular degeneration: A case-control study. Sci Rep. 2017;7:605 pubmed 出版商
  16. Kahraman T, Gucluler G, Simsek I, Yagci F, Yildirim M, Ozen C, et al. Circulating LL37 targets plasma extracellular vesicles to immune cells and intensifies Behçet's disease severity. J Extracell Vesicles. 2017;6:1284449 pubmed 出版商
  17. Millrud C, Kågedal A, Kumlien Georén S, Winqvist O, Uddman R, Razavi R, et al. NET-producing CD16high CD62Ldim neutrophils migrate to tumor sites and predict improved survival in patients with HNSCC. Int J Cancer. 2017;140:2557-2567 pubmed 出版商
  18. Sullivan A, Wang E, Farrell J, Whitaker P, Faulkner L, Peckham D, et al. ?-Lactam hypersensitivity involves expansion of circulating and skin-resident TH22 cells. J Allergy Clin Immunol. 2018;141:235-249.e8 pubmed 出版商
  19. Martin Gayo E, Cronin J, Hickman T, Ouyang Z, Lindqvist M, Kolb K, et al. Circulating CXCR5+CXCR3+PD-1lo Tfh-like cells in HIV-1 controllers with neutralizing antibody breadth. JCI Insight. 2017;2:e89574 pubmed 出版商
  20. O CONNOR D, Clutterbuck E, Thompson A, Snape M, Ramasamy M, Kelly D, et al. High-dimensional assessment of B-cell responses to quadrivalent meningococcal conjugate and plain polysaccharide vaccine. Genome Med. 2017;9:11 pubmed 出版商
  21. Lundell A, Nordström I, Andersson K, Lundqvist C, Telemo E, Nava S, et al. IFN type I and II induce BAFF secretion from human decidual stromal cells. Sci Rep. 2017;7:39904 pubmed 出版商
  22. Serr I, Fürst R, Ott V, Scherm M, Nikolaev A, Gökmen F, et al. miRNA92a targets KLF2 and the phosphatase PTEN signaling to promote human T follicular helper precursors in T1D islet autoimmunity. Proc Natl Acad Sci U S A. 2016;113:E6659-E6668 pubmed
  23. Wang X, Qin W, Zhang Y, Zhang H, Sun B. Endotoxin promotes neutrophil hierarchical chemotaxis via the p38-membrane receptor pathway. Oncotarget. 2016;7:74247-74258 pubmed 出版商
  24. Keefer M, Zheng B, Rosenberg A, Kobie J. Increased Steady-State Memory B Cell Subsets Among High-Risk Participants in an HIV Vaccine Trial. AIDS Res Hum Retroviruses. 2016;32:1143-1148 pubmed
  25. Piepenbrink M, Samuel M, Zheng B, Carter B, Fucile C, Bunce C, et al. Humoral Dysregulation Associated with Increased Systemic Inflammation among Injection Heroin Users. PLoS ONE. 2016;11:e0158641 pubmed 出版商
  26. Gadd V, Patel P, Jose S, Horsfall L, Powell E, Irvine K. Altered Peripheral Blood Monocyte Phenotype and Function in Chronic Liver Disease: Implications for Hepatic Recruitment and Systemic Inflammation. PLoS ONE. 2016;11:e0157771 pubmed 出版商
  27. Kilcollins A, Li J, Hsiao C, Wiemer A. HMBPP Analog Prodrugs Bypass Energy-Dependent Uptake To Promote Efficient BTN3A1-Mediated Malignant Cell Lysis by V?9V?2 T Lymphocyte Effectors. J Immunol. 2016;197:419-28 pubmed 出版商
  28. Vaccari M, Gordon S, Fourati S, Schifanella L, Liyanage N, Cameron M, et al. Adjuvant-dependent innate and adaptive immune signatures of risk of SIVmac251 acquisition. Nat Med. 2016;22:762-70 pubmed 出版商
  29. Loyon R, Picard E, Mauvais O, Queiroz L, Mougey V, Pallandre J, et al. IL-21-Induced MHC Class II+ NK Cells Promote the Expansion of Human Uncommitted CD4+ Central Memory T Cells in a Macrophage Migration Inhibitory Factor-Dependent Manner. J Immunol. 2016;197:85-96 pubmed 出版商
  30. Li H, Borrego F, Nagata S, Tolnay M. Fc Receptor-like 5 Expression Distinguishes Two Distinct Subsets of Human Circulating Tissue-like Memory B Cells. J Immunol. 2016;196:4064-74 pubmed 出版商
  31. Lakschevitz F, Hassanpour S, Rubin A, Fine N, Sun C, Glogauer M. Identification of neutrophil surface marker changes in health and inflammation using high-throughput screening flow cytometry. Exp Cell Res. 2016;342:200-9 pubmed 出版商
  32. Thibaudin M, Chaix M, Boidot R, Végran F, Derangère V, Limagne E, et al. Human ectonucleotidase-expressing CD25high Th17 cells accumulate in breast cancer tumors and exert immunosuppressive functions. Oncoimmunology. 2016;5:e1055444 pubmed
  33. Roan F, Stoklasek T, Whalen E, Molitor J, Bluestone J, Buckner J, et al. CD4+ Group 1 Innate Lymphoid Cells (ILC) Form a Functionally Distinct ILC Subset That Is Increased in Systemic Sclerosis. J Immunol. 2016;196:2051-2062 pubmed 出版商
  34. Hu M, Li K, Maskey N, Xu Z, Yu F, Peng C, et al. Overexpression of the chemokine receptor CXCR3 and its correlation with favorable prognosis in gastric cancer. Hum Pathol. 2015;46:1872-80 pubmed 出版商
  35. Mitson Salazar A, Yin Y, Wansley D, Young M, Bolan H, Arceo S, et al. Hematopoietic prostaglandin D synthase defines a proeosinophilic pathogenic effector human T(H)2 cell subpopulation with enhanced function. J Allergy Clin Immunol. 2016;137:907-18.e9 pubmed 出版商
  36. Masek Hammerman K, Peeva E, Ahmad A, Menon S, Afsharvand M, Peng Qu R, et al. Monoclonal antibody against macrophage colony-stimulating factor suppresses circulating monocytes and tissue macrophage function but does not alter cell infiltration/activation in cutaneous lesions or clinical outcomes in patients with cutaneous lupu. Clin Exp Immunol. 2016;183:258-70 pubmed 出版商
  37. Denkovskij J, Rudys R, Bernotiene E, Minderis M, Bagdonas S, Kirdaite G. Cell surface markers and exogenously induced PpIX in synovial mesenchymal stem cells. Cytometry A. 2015;87:1001-11 pubmed 出版商
  38. Mikucki M, Fisher D, Matsuzaki J, Skitzki J, Gaulin N, Muhitch J, et al. Non-redundant requirement for CXCR3 signalling during tumoricidal T-cell trafficking across tumour vascular checkpoints. Nat Commun. 2015;6:7458 pubmed 出版商
  39. Yawata N, Selva K, Liu Y, Tan K, Lee A, Siak J, et al. Dynamic change in natural killer cell type in the human ocular mucosa in situ as means of immune evasion by adenovirus infection. Mucosal Immunol. 2016;9:159-70 pubmed 出版商
  40. McArthur M, Fresnay S, Magder L, Darton T, Jones C, Waddington C, et al. Activation of Salmonella Typhi-specific regulatory T cells in typhoid disease in a wild-type S. Typhi challenge model. PLoS Pathog. 2015;11:e1004914 pubmed 出版商
  41. Lee J, Jeong I, Joh J, Jung Y, Sim S, Choi B, et al. Differential expression of CD57 in antigen-reactive CD4+ T cells between active and latent tuberculosis infection. Clin Immunol. 2015;159:37-46 pubmed 出版商
  42. Zsiros E, Duttagupta P, Dangaj D, Li H, Frank R, Garrabrant T, et al. The Ovarian Cancer Chemokine Landscape Is Conducive to Homing of Vaccine-Primed and CD3/CD28-Costimulated T Cells Prepared for Adoptive Therapy. Clin Cancer Res. 2015;21:2840-50 pubmed 出版商
  43. Chovancová J, Bernard T, Stehlíková O, Sálek D, Janíková A, Mayer J, et al. Detection of Minimal Residual Disease in Mantle Cell Lymphoma. Establishment of Novel 8-Color Flow Cytometry Approach. Cytometry B Clin Cytom. 2014;: pubmed 出版商
  44. Alnabhan R, Madrigal A, Saudemont A. Differential activation of cord blood and peripheral blood natural killer cells by cytokines. Cytotherapy. 2015;17:73-85 pubmed 出版商
  45. Toapanta F, Simon J, Barry E, Pasetti M, Levine M, Kotloff K, et al. Gut-Homing Conventional Plasmablasts and CD27(-) Plasmablasts Elicited after a Short Time of Exposure to an Oral Live-Attenuated Shigella Vaccine Candidate in Humans. Front Immunol. 2014;5:374 pubmed 出版商
  46. Ohue Y, Kurose K, Mizote Y, Matsumoto H, Nishio Y, Isobe M, et al. Prolongation of overall survival in advanced lung adenocarcinoma patients with the XAGE1 (GAGED2a) antibody. Clin Cancer Res. 2014;20:5052-63 pubmed 出版商
  47. Walters M, Ebsworth K, Berahovich R, Penfold M, Liu S, Al Omran R, et al. Inhibition of CXCR7 extends survival following irradiation of brain tumours in mice and rats. Br J Cancer. 2014;110:1179-88 pubmed 出版商
  48. Huang H, Xu X, Yao C, Cai M, Qian Y, Wang X, et al. Serum levels of CXCR3 ligands predict T cell-mediated acute rejection after kidney transplantation. Mol Med Rep. 2014;9:45-50 pubmed 出版商
  49. Melis L, Van Praet L, Pircher H, Venken K, Elewaut D. Senescence marker killer cell lectin-like receptor G1 (KLRG1) contributes to TNF-? production by interaction with its soluble E-cadherin ligand in chronically inflamed joints. Ann Rheum Dis. 2014;73:1223-31 pubmed 出版商
  50. Zhou S, Ma J, Qu H, Liu Z, He W, Wang J, et al. Characterization of Th1- and Th2-associated chemokine receptor expression in spleens of patients with immune thrombocytopenia. J Clin Immunol. 2013;33:938-46 pubmed 出版商
  51. Denkert C, Loibl S, Noske A, Roller M, Müller B, Komor M, et al. Tumor-associated lymphocytes as an independent predictor of response to neoadjuvant chemotherapy in breast cancer. J Clin Oncol. 2010;28:105-13 pubmed 出版商